E-LIB Suche - Ergebnisse für: Dreyer, Nancy A.

1

Longitudinal Molecular and Serological Evidence of SARS-CoV..:

Sánchez-Soliño, Olga ; Kilpatrick, Ryan D. ; Johnson, Christopher...
Infectious Diseases and Therapy. 13 (2024) 4 - p. 633-645 , 2024

Link: https://doi.org/10.1007/..

2

Power to the People: Why person-generated health data is im..:

Dreyer, Nancy A ; Blackburn, Stella C F
American Journal of Epidemiology. , 2024

Link: https://doi.org/10.1093/..

3

COVID-19 Vaccination Reactions and Risk of Breakthrough Inf..:

Dreyer, Nancy A ; Knuth, Kendall B ; Xie, Yiqiong..
JMIR Diabetes. 9 (2024) - p. e45536 , 2024

Link: https://doi.org/10.2196/..

4

Cognitive and other neuropsychiatric symptoms in COVID-19: ..:

Largent, Joan ; Xie, Yiqiong ; Knuth, Kendall B...
BMJ Open. 13 (2023) 6 - p. e069118 , 2023

Link: https://doi.org/10.1136/..

5

Daily COVID-19 symptom assessment over 28 days – findings f..:

Brinkley, Emma ; Knuth, Kendall ; Kwon, Tom...
Journal of Patient-Reported Outcomes. 7 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

6

Tactical Considerations for Designing Real-World Studies: F..:

Dreyer, Nancy ; Mack, Christina
Pragmatic and Observational Research. 14 (2023) - p. 101-110 , 2023

Link: https://doi.org/10.2147/..

7

Strengthening evidence-based medicine with real-world evide..:

Dreyer, Nancy A
The Lancet Healthy Longevity. 3 (2022) 10 - p. e641-e642 , 2022

Link: https://doi.org/10.1016/..

8

EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake Coun..:

Kilpatrick, Ryan D. ; Sánchez-Soliño, Olga ; Alami, Negar Niki...
Infectious Diseases and Therapy. 11 (2022) 2 - p. 899-911 , 2022

Link: https://doi.org/10.1007/..

9

How frequent are acute reactions to COVID-19 vaccination an..:

Dreyer, Nancy ; Reynolds, Matthew W. ; Albert, Lisa...
Vaccine. 40 (2022) 12 - p. 1904-1912 , 2022

Link: https://doi.org/10.1016/..

10

Demonstrating Benefit-Risk Profiles of Novel Therapeutic St..:

Helanterä, Ilkka ; Snyder, Jon ; Åsberg, Anders...
Transplant International. 35 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

11

COVID-19 Vaccination Breakthrough Infections in a Real-Worl..:

Reynolds, Matthew W ; Xie, Yiqiong ; Knuth, Kendall B...
Infection and Drug Resistance. 15 (2022) - p. 5167-5182 , 2022

Link: https://doi.org/10.2147/..

12

Evaluation of Treatment Effect in Underrepresented Populati..:

Sridhara, Rajeshwari ; Marchenko, Olga ; Jiang, Qi...
Statistics in Biopharmaceutical Research. 15 (2022) 2 - p. 450-456 , 2022

Link: https://doi.org/10.1080/..

13

COVID-19 Vaccination Breakthrough Infections in a Real-Worl..:

Reynolds, Matthew W ; Xie, Yiqiong ; Knuth, Kendall B...
Infection and Drug Resistance. 15 (2022) - p. 5543-5544 , 2022

Link: https://doi.org/10.2147/..

14

When Can We Trust Real‐World Data To Evaluate New Medical T..:

Simon, Gregory E. ; Bindman, Andrew B. ; Dreyer, Nancy A....
Clinical Pharmacology & Therapeutics. 111 (2021) 1 - p. 24-29 , 2021

Link: https://doi.org/10.1002/..

15

Identification of a Vulnerable Group for Post-Acute Sequela..:

Dreyer, Nancy ; Petruski-Ivleva, Natalia ; Albert, Lisa...
International Journal of General Medicine. 14 (2021) - p. 3941-3949 , 2021

Link: https://doi.org/10.2147/..